Medical imaging companies are heading in that direction, developing molecules with radioactive markers that will bind to amyloid plaques. Patients could receive an injection that would prompt regions of the brain to become colorized in a scan and reveal the location of those Alzheimer's-related plaques, the Wall Street Journal describes.
Wednesday, April 21, 2010
On the horizon: A better way to diagnose Alzheimer's disease
Medical imaging companies are heading in that direction, developing molecules with radioactive markers that will bind to amyloid plaques. Patients could receive an injection that would prompt regions of the brain to become colorized in a scan and reveal the location of those Alzheimer's-related plaques, the Wall Street Journal describes.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment